Quest Diagnostics Inc. revenue by year
Over the 10 fiscal years shown, revenue went from $7.21B (year ended Dec 31, 2016) to $11.04B (year ended Dec 31, 2025), a compound annual growth rate of 4.8%. The fastest growth was +22.1% in the year ended Dec 31, 2020; the weakest year was −8.4% (year ended Dec 31, 2022).
Annual revenue
| Fiscal year ended | Revenue (USD) | Change | XBRL concept | Reported in |
|---|---|---|---|---|
| Dec 31, 2025 | $11.04B | +11.8% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 26, 2026 |
| Dec 31, 2024 | $9.87B | +6.7% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 26, 2026 |
| Dec 31, 2023 | $9.25B | −6.4% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 26, 2026 |
| Dec 31, 2022 | $9.88B | −8.4% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 20, 2025 |
| Dec 31, 2021 | $10.79B | +14.3% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 22, 2024 |
| Dec 31, 2020 | $9.44B | +22.1% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 21, 2023 |
| Dec 31, 2019 | $7.73B | +2.6% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 28, 2022 |
| Dec 31, 2018 | $7.53B | +1.7% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 22, 2021 |
| Dec 31, 2017 | $7.40B | +2.6% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 20, 2020 |
| Dec 31, 2016 | $7.21B | −3.7% | SalesRevenueNet | 10-K filed Feb 21, 2019 |
Quest Diagnostics Inc. reported revenue under 2 different XBRL concepts across these years (often after the 2018 change in revenue-recognition rules, ASC 606). Each row shows the concept used, so you can judge comparability.
Quarterly revenue
Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.
| Quarter | Revenue (USD) | vs same quarter a year earlier | Source |
|---|---|---|---|
| 3 months ended Sep 30, 2026 | $3.10B | +10.0% | 10-Q filed Oct 23, 2026 |
| 3 months ended Jun 30, 2026 | $3.04B | +10.2% | 10-Q filed Jul 23, 2026 |
| 3 months ended Mar 31, 2026 | $2.90B | +9.2% | 10-Q filed Apr 22, 2026 |
| 3 months ended Sep 30, 2025 | $2.82B | +13.2% | 10-Q filed Oct 23, 2026 |
| 3 months ended Jun 30, 2025 | $2.76B | +15.2% | 10-Q filed Jul 23, 2026 |
| 3 months ended Mar 31, 2025 | $2.65B | +12.1% | 10-Q filed Apr 22, 2026 |
| 3 months ended Sep 30, 2024 | $2.49B | +8.4% | 10-Q filed Oct 21, 2025 |
| 3 months ended Jun 30, 2024 | $2.40B | +2.5% | 10-Q filed Jul 23, 2025 |
Source: SEC EDGAR XBRL company facts for CIK 1022079 (raw data). Most recent filing in this dataset: 10-Q filed Oct 23, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.